The Effect of Vagus Nerve Stimulation on the Inflammatory Response After Lung Lobectomy
NCT ID: NCT03204968
Last Updated: 2017-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
130 participants
INTERVENTIONAL
2015-12-01
2017-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Transauricular Vagus Nerve Stimulation on Postoperative Pain Management in Video Assisted Thoracic Surgery
NCT06912399
Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a Pilot Study
NCT01944228
Effects of taVNS on Postoperative Pain in Complex Spinal Surgery
NCT07330973
Auricular Vagal Nerve Stimulation for Spinal Fusion Surgery
NCT07218133
Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS
NCT05058742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
No interventions assigned to this group
Treated
Vagus nerve stimulation
transcutaneous Intermittent stimulation of the vagus nerve using neurostimulator V (Ducest®, Germany)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vagus nerve stimulation
transcutaneous Intermittent stimulation of the vagus nerve using neurostimulator V (Ducest®, Germany)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult
* Open surgery
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otto Wagner Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Salama
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Mueller, MD, PhD
Role: STUDY_DIRECTOR
Otto Wagner Hospital
Mohamed Salama, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Otto Wagner Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Thoracic Surgery, Otto-Wagner Hospital
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Salama M, Akan A, Mueller MR. Transcutaneous Stimulation of Auricular Branch of the Vagus Nerve Attenuates the Acute Inflammatory Response After Lung Lobectomy. World J Surg. 2020 Sep;44(9):3167-3174. doi: 10.1007/s00268-020-05543-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vagus Stimulation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.